IAPP and type 2 diabetes mellitus: To the best of our knowledge, this is the first study to report the inhibition of IAPP-Aβ40 co-aggregation by a polyphenolic small molecule and our current in vitro data holds significant impact in establishing a preventative therapy against the association between T2D and AD.